Fig 1.
Flow diagram of participants in the cross-sectional study.
Table 1.
Characteristics of the type 1 diabetic and non-diabetic patients.
Fig 2.
Distribution of the serum FGF21 concentration in T1DM and non-diabetic middle-aged and elderly subjects.
Closed circles (●) indicate male T1DM patients, and open circles (○) indicate female T1DM patients. Closed triangles (▲) indicate male non-diabetic participants and open triangles (△) indicate female non-diabetic participants. Cross mark (×) shows undetectable serum FGF21 levels in each group. Horizontal lines represent the median values.
Table 2.
Characteristics of type 1 diabetic patients with and without diabetic complications.
Table 3.
Correlations of the serum FGF21 level with the other variables in type 1 diabetic patients.
Fig 3.
Correlation of the serum FGF21 level with basal insulin dose (A) and bolus insulin dose (B) in middle-aged and elderly T1DM patients. Closed circles (●) indicate male patients, and open circles (○) indicate female patients.
Table 4.
Stepwise multiple linear regression analysis of FGF21 in type 1 diabetes patients.